Phagocytosis and Killing of Carbapenem-Resistant ST258 Klebsiella pneumoniae by Human Neutrophils

Journal of Infectious Diseases

Volumn 213, Issue 10, 2016, Pages 1615-1622

  Kobayashi, Scott D ^a   Porter, Adeline R ^a   Dorward, David W ^b   Brinkworth, Amanda J ^a,d   Chen, Liang ^c   Kreiswirth, Barry N ^c   Deleo, Frank R ^a  

^a Laboratory of Bacteriology   (United States)

^b National Institute   (New Zealand)

^c PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

^d WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Klebsiella pneumoniae; Neutrophil; Phagocytosis

Indexed keywords

REACTIVE OXYGEN METABOLITE; CARBAPENEM DERIVATIVE;

APOPTOSIS; ARTICLE; BACTERIAL SURVIVAL; BACTERICIDAL ACTIVITY; CARBAPENEM RESISTANT KLEBSIELLA PNEUMONIAE; CONTROLLED STUDY; HUMAN; HUMAN CELL; KLEBSIELLA PNEUMONIAE; NEUTROPHIL; NONHUMAN; OPSONIZATION; PHAGOCYTOSIS; PHAGOSOME; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; ANIMAL; ANTIBIOTIC RESISTANCE; BACTERIUM IDENTIFICATION; DRUG EFFECTS; FEMALE; GENETICS; IMMUNOLOGY; KLEBSIELLA INFECTIONS; METABOLISM; MICROBIOLOGY; MULTILOCUS SEQUENCE TYPING; RABBITS AND HARES;

ANIMALS; BACTERIAL TYPING TECHNIQUES; CARBAPENEMS; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MULTILOCUS SEQUENCE TYPING; NEUTROPHILS; PHAGOCYTOSIS; RABBITS; REACTIVE OXYGEN SPECIES;

EID: 84969921417     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiw001     Document Type: Article

References (46)

1. Magill SS, Edwards JR, Bamberg W, et al. Multistate point-prevalence survey of health care-associated infections. New Engl J Med 2014; 370:1198-208.
2. da Silva RM, Traebert J, Galato D. Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae: a review of epidemiological and clinical aspects. Expert Opin Biol Ther 2012; 12:663-71.
3. Kitchel B, Rasheed JK, Patel JB, et al. Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolates in the United States: clonal expansion of multilocus sequence type 258. Antimicrob Agents Chemother 2009; 53:3365-70.
4. Nordmann P, Naas T, Poirel L. Global spread of Carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis 2011; 17:1791-8.
5. Daikos GL, Tsaousi S, Tzouvelekis LS, et al. Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems. Antimicrob Agents Chemother 2014; 58:2322-8.
6. Endimiani A, Depasquale JM, Forero S, et al. Emergence of blaKPC-containing Klebsiella pneumoniae in a long-term acute care hospital: a new challenge to our healthcare system. J Antimicrob Chemother 2009; 64:1102-10.
7. Falagas ME, Tansarli GS, Karageorgopoulos DE, Vardakas KZ. Deaths attributable to carbapenem-resistant Enterobacteriaceae infections. Emerg Infect Dis 2014; 20:1170-5.
8. Gomez-Simmonds A, Greenman M, Sullivan SB, et al. Population structure of Klebsiella pneumoniae causing bloodstream infections at a New York City tertiary care hospital: diversification of multidrug-resistant isolates. J Clin Microbiol 2015; 53:2060-7.
9. Cuzon G, Naas T, Truong H, et al. Worldwide diversity of Klebsiella pneumoniae that produce beta-lactamase blaKPC-2 gene. Emerg Infect Dis 2010; 16:1349-56.
10. Adler A, Carmeli Y. Dissemination of the Klebsiella pneumoniae carbapenemase in the health care settings: tracking the trails of an elusive offender. mBio 2011; 2: e00280-11.
11. Chen L, Mathema B, Chavda KD, DeLeo FR, Bonomo RA, Kreiswirth BN. Carbapenemase-producing Klebsiella pneumoniae: molecular and genetic decoding. Trends Microbiol 2014; 22:686-96.
12. DeLeo FR, Nauseef WM. Granulocytic Phagocytes. In: Bennett JE, Dolin R, Blaser MJ, eds. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 8th ed. Vol.1. Philedelphia, PA: Elsevier 2014:78-92.
13. Rehm SR, Gross GN, Pierce AK. Early bacterial clearance from murine lungs. Species-dependent phagocyte response. J Clin Invest 1980; 66:194-9.
14. Bullen JJ, Leach PA, Lange L. Abolition of resistance to Klebsiella pneumoniae by anti-polymorphonuclear leucocyte IgG. Immunology 1980; 39:47-52.
15. Fukutome T, Mitsuyama M, Takeya K, Nomoto K. Importance of antiserum and phagocytic cells in the protection of mice against infection by Klebsiella pneumoniae. J Gen Microbiol 1980; 119:225-9.
16. Valdez JM, Scheinberg P, Young NS,Walsh TJ. Infections in patients with aplastic anemia. Semin Hematol 2009; 46:269-76.
17. Satlin MJ, Calfee DP, Chen L, et al. Emergence of carbapenem-resistant Enterobacteriaceae as causes of bloodstream infections in patients with hematologic malignancies. Leuk Lymphoma 2013; 54:799-806.
18. Hirche TO, Gaut JP, Heinecke JW, Belaaouaj A. Myeloperoxidase plays critical roles in killing Klebsiella pneumoniae and inactivating neutrophil elastase: effects on host defense. J Immunol 2005; 174:1557-65.
19. Belaaouaj A, McCarthy R, Baumann M, et al. Mice lacking neutrophil elastase reveal impaired host defense against gram negative bacterial sepsis. Nat Med 1998; 4:615-8.
20. Tomas JM, Benedi VJ, Ciurana B, Jofre J. Role of capsule and O antigen in resistance of Klebsiella pneumoniae to serum bactericidal activity. Infect Immun 1986; 54:85-9.
21. Voyich JM, Braughton KR, Sturdevant DE, et al. Insights into mechanisms used by Staphylococcus aureus to avoid destruction by human neutrophils. J Immunol 2005; 175:3907-19.
22. Kobayashi SD, Voyich JM, Buhl CL, Stahl RM, DeLeo FR. Global changes in gene expression by human polymorphonuclear leukocytes during receptor-mediated phagocytosis: cell fate is regulated at the level of gene expression. Proc Natl Acad Sci U S A 2002; 99:6901-6.
23. DeLeo FR, Allen LA, Apicella M, Nauseef WM. NADPH oxidase activation and assembly during phagocytosis. J Immunol 1999; 163:6732-40.
24. Bylund J, Bjornsdottir H, Sundqvist M, Karlsson A, Dahlgren C. Measurement of respiratory burst products, released or retained, during activation of professional phagocytes. Methods Mol Biol 2014; 1124:321-38.
25. Kobayashi SD, Braughton KR, Whitney AR, et al. Bacterial pathogens modulate an apoptosis differentiation program in human neutrophils. Proc Natl Acad Sci U S A 2003; 100:10948-53.
26. Kobayashi SD, Braughton KR, Palazzolo-Ballance AM, et al. Rapid neutrophil destruction following phagocytosis of Staphylococcus aureus. J Innate Immun 2010; 2:560-75.
27. Lu T, Porter AR, Kennedy AD, Kobayashi SD, DeLeo FR. Phagocytosis and killing of Staphylococcus aureus by human neutrophils. J Innate Immun 2014; 6:639-49.
28. Domenico P, Salo RJ, Cross AS, Cunha BA. Polysaccharide capsule-mediated resistance to opsonophagocytosis in Klebsiella pneumoniae. Infect Immun 1994; 62:4495-9.
29. Williams P, Lambert PA, Brown MR, Jones RJ. The role of the O and K antigens in determining the resistance of Klebsiella aerogenes to serum killing and phagocytosis. J Gen Microbiol 1983; 129:2181-91.
30. Baer H, Ehrenworth L. The pathogenicity of Klebsiella pneumoniae for mice: the relationship to the quantity and rate of production of type-specific capsular polysaccharide. J Bacteriol 1956; 72:713-7.
31. Hall HE, Humphries JC. The relationship between insusceptibility to phagocytosis and virulence of certain Klebsiella pneumoniae strains. J Infect Dis 1958; 103:157-62.
32. Kabha K, Nissimov L, Athamna A, et al. Relationships among capsular structure, phagocytosis, and mouse virulence in Klebsiella pneumoniae. Infect Immunity 1995; 63:847-52.
33. Capsoni F, Minonzio F, Venegoni E, et al. In vitro and ex vivo effect of RU41740 on human polymorphonuclear leukocyte function. Int J Immunopharmacol 1988; 10:121-33.
34. Ko WC, Paterson DL, Sagnimeni AJ, et al. Community-acquired Klebsiella pneumoniae bacteremia: global differences in clinical patterns. Emerg Infect Dis 2002; 8:160-6.
35. Watson RW, Redmond HP,Wang JH, Condron C, Bouchier-Hayes D. Neutrophils undergo apoptosis following ingestion of Escherichia coli. J Immunol 1996; 156:3986-92.
36. Savill JS, Wyllie AH, Henson JE,Walport MJ, Henson PM, Haslett C. Macrophage phagocytosis of aging neutrophils in inflammation. Programmed cell death in the neutrophil leads to its recognition by macrophages. J Clin Invest 1989; 83:865-75.
37. Greenlee-Wacker MC, Rigby KM, Kobayashi SD, Porter AR, DeLeo FR, Nauseef WM. Phagocytosis of Staphylococcus aureus by human neutrophils prevents macrophage efferocytosis and induces programmed necrosis. J Immunol 2014; 192:4709-17.
38. DeLeo FR. Modulation of phagocyte apoptosis by bacterial pathogens. Apoptosis 2004; 9:399-413.
39. Roe EA, Jones RJ. Vaccination against Klebsiella aerogenes. J Hyg (Lond) 1984; 93:355-63.
40. Jones RJ, Roe EA. Vaccination against 77 capsular types of Klebsiella aerogenes with polyvalent Klebsiella vaccines. J Med Microbiol 1984; 18:413-21.
41. Roe EA, Jones RJ, Dyster RE. Passive immunization of mice against Klebsiella aerogenes. Br J Exp Pathol 1986; 67:25-32.
42. Cryz SJ Jr, Furer E, Germanier R. Safety and immunogenicity of Klebsiella pneumoniae K1 capsular polysaccharide vaccine in humans. J Infect Dis 1985; 151:665-71.
43. Cryz SJ Jr, Furer E, Germanier R. Protection against fatal Klebsiella pneumoniae burn wound sepsis by passive transfer of anticapsular polysaccharide. Infect Immun 1984; 45:139-42.
44. Cryz SJ Jr, Furer E, Germanier R. Purification and vaccine potential of Klebsiella capsular polysaccharides. Infect Immun 1985; 50:225-30.
45. Campbell WN, Hendrix E, Cryz S Jr., Cross AS. Immunogenicity of a 24-valent Klebsiella capsular polysaccharide vaccine and an eight-valent Pseudomonas O-polysaccharide conjugate vaccine administered to victims of acute trauma. Clin Infect Dis 1996; 23:179-81.
46. DeLeo FR, Otto M. An antidote for Staphylococcus aureus pneumonia? J Exp Med 2008; 205:271-4.